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Introduction: Mitochondrias are involved in many cellular pro- 
cesses and mitochondrial dysfunctions have been associated 
with apoptosis, aging and number of pathological conditions, in- 
cluding osteoarthritis (OA). Mitochondrial proteins are an attrac- 
tive target to study the metabolism of chondrocyte and its role in 
the cartilage degradation. However, contaminating proteins has 
been the major problem in all the mitochondrial proteomic re- 
search. 
Aim: To obtain a Mitochondrial 2-DE proteome map of the human 
normal articular chondrocyte. To study whether purification of mi- 
tochondrias with density gradient ultracentrifugation using percoll 
and separation of proteins by 2D-E were useful to analysis the 
mitochondrial proteins of primary human normal articular chon- 
drocytes 
Material and Methods: Cells were isolated from five cartilages 
collected from autopsies without history of joint disease. Cul- 
tured cells were used to obtain different protein extracts (chon- 
drocytes: total chondrocyte extract (CE); cytosol-enriched frac- 
tion (CY); crude mitochondria fraction (CM) and purified mito- 
chondria fraction (PM)) which were resolved by 2-DE and vi- 
sualized by silver nitrate or Coomassie blue staining. Spots 
were excised from the gels and analyzed using matrix-assisted 
laser desorption/ionization-time of flight (MALDI-TOF) or MALDI- 
TOF/TOF mass spectrometry. 
Results: Results showed that purification of mitochondrias with 
density gradient ultracentrifugation using percoll and separation 
of proteins by 2D-E were useful to analysis the mitochondrial pro- 
teins of primary human normal articular chondrocytes. We iden- 
tified a total of 62 unambiguous proteins from 90 excised spots 
(69%) by means of peptide mass fingerprinting (PMF). The spots 
were excised from each of three 2D-E gels carrying proteins from 
the PM fraction. Further 4 samples that could not be recognized 
with the information available in the PMF were identified by tan- 
dem mass spectrometry using MALDI-TOF/TOF technology. All 
together, our analysis leads to the identification of 66 spots that 
represent 45 different proteins. Analysis of proteins showed that 
32% were located in the mitochondria, 15% in endoplasmic retic- 
ulum and 24% in the cytoplasm. According the biological function 
21% are involved in protein targeting, 11% in signalling, 11% in 
glycolisys, 11% RNA/DNA protein synthesis, 11% in OXPHOS 
and 4% in redox. During aging, the purified mitochondrial fraction 
of chondrocytes howed increases in antioxidative proteins such 
as SOMD. 
Conclusion: Because this technique allows the simultaneous 
identification and quantification of mitochondrial proteins in chon- 
drocytes, it may help to determine alterations in protein levels that 
occur in cartilage degradation associated with OA. 
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RD Graft, JW Neal 
Orthopaedics, Thurston Arthritis Res. Center, University of North 
Carolina at Chapel Hill, Chapel Hill, NC 
Aim of Study: Transglutaminases in articular cartilage ECM are 
responsible for retention and activation of latent TGFI~, and have 
been implicated in promotion of chondrocyte hypertrophy and 
CPPD crystal formation. TGases have been localized to the PCM 
of both normal and aging/OA chondrocytes, yet the role of TGase 
in the formation of healthy cartilage matrix and the organization 
of the chondrocyte pericellular matrix is not well understood. 
Methods: Porcine articular cartilage was harvested from com- 
mercially obtained knee joints. Enzymatically isolated chondro- 
cytes were grown in monolayer culture or in alginate beads in 
serum supplemented media containing monodansylcadaverine 
(MDC), or SY2011, a small competitive peptide inhibitor (PVKG). 
GAGs and type II collagen in collected media and GuHCI extracts 
were measured by DMMB assay or ELISA after 7 days. Cell via- 
bility was measured by MTT assay. Alginate bead cultures were 
aldehyde-fixed and dissolved after 3 days and chondrocytes were 
cast in thin agarose films. PCM were examined by immunocyto- 
chemistry using antibodies for types II and Vl collagen and fi- 
bronectin. 
Results: There was no change in GAG accumulation in media 
or cell-associated matrix by MDC at concentrations up to 50 I~M 
(p=0.48; n=5). A small decrease (25%; p=0.05) was seen at 100 
I~M. GAGs were unaffected by the peptide inhibitor SY2011 up to 
75 I~M. In contrast, concentration-dependent decreases in type 
II collagen were observed with both inhibitors. MDC reduced to- 
tal collagen accumulation by 21 and 27% at 12.5 and 25 I~M, 
respectively (p=0.017, 0.002), and at 100 I~M type II collagen 
was reduced by 65% (p=0.03). SY2011 lowered type II colla- 
gen production by 26% at 18.75 I~M (p=0.02) and 47% at 75 I~M 
(p=0.001) in a single experiment (4 replicates per group). Nei- 
ther MDC nor SY2011 shifted the distribution of GAGs or type II 
collagen from cell associated matrix to culture media. MDC de- 
creased cell viability only 6-10% (p~0.03); SY2011 had no effect 
at 18.75 and 37.5 I~M (p>0.1) but reduced viability by 12% at 
751~M (p=0.006). Chondrocytes had little or no ECM staining im- 
mediately after isolation. Some type Vl collagen and fibronectin 
staining was evident within 24 hours, and after three days, chon- 
drocytes had elaborated a PCM rich in type Vl and type II colla- 
gen. Fibronectin staining was mostly limited to the cell surface. 
MDC and SY2011, at their highest concentrations, did not inhibit 
the deposition of collagens in the PCM, and cell death was not 
apparent. 
Conclusions: Transglutaminase activity plays a significant part 
in the production of extracellular matrix by normal articular chon- 
drocytes; however, despite the reported co-localization of tissue 
transglutaminase with pericellular matrix molecules, a role for 
TGase in the organization/retention f the PCM is not supported 
by these results. 
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Background: Osteoarthritis is characterized by the progressive 
destruction of articular cartilage. Damage to the collagen net- 
work, one of the first signs of OA, is often considered irreversible, 
whereas proteoglycan loss is reversible. However, it was recently 
demonstrated that adult human cartilage does possess the ca- 
pacity to synthesize collagen and incorporate it correctly into the 
existing matrix. In addition, treatment of cartilage transplants with 
collagen-degrading enzymes, greatly enhances the integration 
into the surrounding recipient issue, indicating effective anabolic 
processes. These results open the possibility for the development 
of novel OA therapies directed at the modulation of collagen net- 
work formation. To fully appreciate the potential of this approach 
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it is crucial to better understand the processes that direct the for- 
mation of a functional collagen network in cartilage. The present 
study was designed to test whether initial blockage of collagen 
crosslinking would stimulate collagen synthesis and whether sub- 
sequent formation of the crosslinks would result in a functional 
collagen network. 
Methods: Bovine articular chondrocytes were cultured in alginate 
beads for 5 weeks in the presence or absence of the lysyl oxidase 
inhibitor BAPN (0.1 mM, 0.25mM or 0.5mM) followed by 5 weeks 
without BAPN. Proteoglycan synthesis (colorimetric assay), colla- 
gen synthesis and amout of crosslinks were measured biochem- 
ically (HPLC) at several timepoints. 
Results: Inhibition of lysyl oxidase with BAPN caused an in- 
crease in total collagen levels. As from week 5, there was ap- 
proximately 1.5 times more collagen deposition in cultures sup- 
plemented with BAPN than in the control condition, reaching 
1.84 times more after 10 weeks (8.9 I~g collagen/bead vs. 16.4 
i~g/bead). There was no difference in the proteoglycan deposi- 
tion. Until week 6 there was a low amount of crosslinks in the 
collagen detectable in the matrix produced by chondrocytes in 
the presence of BAPN (0.18 pmol HP/pmol collagen) whereas 
collagen deposited without the presence of BAPN had a higher 
level of crosslinking (0.53 pmol HP/pmol collagen). From week 8 
on, 3 weeks after removal of BAPN, the amount of crosslinks in 
all three conditions approached the level of the control condition 
(0.70 HP/collagen in the control condition vs. 0.60 HP/collagen 
with BAPN) in week 10. No dosis effect was observed for BAPN. 
Conclusion: Blockage of collagen crosslinking with BAPN at first 
stimulates collagen synthesis compared to the control condition, 
followed by the formation of an equal amount of crosslinks after 
removal of the lysyl oxidase inhibitor. The effect of more colla- 
gen with the same amount of crosslinks per collagen molecule 
on mechanical properties requires further investigation. 
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The goal of this study is to demonstrate the role of the subchon- 
dral bone in the development and progression of hyaline cartilage 
degeneration in the knee joint. 
We utilized a murine model of Osteogenesis Imperfecta (OI) to 
determine whether abnormalities in bone predispose the joint to 
the development of osteoarthritis. 
OI is a genetic disease of humans that is caused by a mutation in 
type I collagen and is expressed in bone and ligament, but not in 
hyaline articular cartilage. The animals employed were a knock-in 
model of type IV OI and age matched wild-type (WT) controls. 
High resolution micro-computed tomography (micro-CT) and 
micro-magnetic resonance imaging (micro-MRI) with gadolinium 
contrast enhancement, as well as histologic evaluation, were em- 
ployed to study the knee joints of a pair of OI and a pair of WT 
animals age 2, 4, 6, and 12 months and one animal each at 22 
months. 
The results document for the first time that OI mice develop 
rapidly progressive OA. Micro-CT and micro-MRI documented 
age-related joint space narrowing, extra-articular ossification, and 
progressive subchondral bone thickening and cyst formation in 
the OI mice. Histologic examination showed typical aggressive 
cartilage destruction with osteophyte formation in the OI mice. 
These results clearly demonstrate that abnormalities in subchon- 
dral bone can lead to rapidly progressive OA in the absence of 
intrinsic cartilage abnormalities. 
Moreover, the data suggest that OI mice might serve as a useful 
model of OA that can be employed to examine the pathophysiol- 
ogy of cartilage damage as well as the impact of therapies. 
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Objective: Both matrix metalloprotease (MMP) activity and 
cathepsin K activity have been implicated in cartilage turnover. 
We investigated the relative contribution of MMP activity and 
cathepsin K activity in cartilage degradation usingex vivo and in 
vivo models. 
Methods: Bovine articular cartilage explants were cultured in 
presence of oncostatin M (OSM) 10 ng/ml, tumor necrosis 
factor-a (TNF-~) 20 ng/ml in the presence or absence of the 
broad-spectrum MMP activity inhibitor GM6001 and the cys- 
teine protease inhibitor E64. Cartilage degradation was evalu- 
ated in the conditioned medium by measurement of crosslinked 
C-telopeptide fragments of type II collagen (CTX-II) and gly- 
cosaminoglycans (GAG), which were compared to immunohisto- 
chemical evaluations of proteoglycans and CTX-II. We assessed 
MMP expression by gelatine zymography and cathepsin K ex- 
pression by immunohistochemistry. 
Results: OSM and TNF-~ in combination induced a 500-fold in- 
crease in cartilage degradation products measured by CTX-II 
(P<0.001) compared to vehicle control. The growth factors po- 
tently induced MMP expression, assessed by zymography, and 
cathepsin K expression investigated by immunohistochemistry. 
Inhibition of MMP activity by GM6001 completely abrogated CTX- 
II release (P<0.001) and inhibited proteoglycan release by 72% 
(p<0.001). In contrast, E64 resulted in an increased CTX-II re- 
lease by 100% (P<0.05) and inhibited GAG release by 33% 
(p<0.01). An up-regulation of CTX-II fragments was confirmed 
in vivo in cathepsin K null mice. 
Conclusions: Inhibition of MMP activity reduced both proteo- 
glycan-loss and type II collagen degradation. In contrast, inhibi- 
tion of cysteine proteases resulted in an increase rather than a 
decrease in collagen type II degradation, suggesting compensa- 
tion by other proteases. 
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Aim of study: In this study we investigated if the inhibition of 
MRC is able to modulate the inflammatory response in human 
OA chondrocytes. 
Methods: Human OA chondrocytes were isolated from cartilage 
obtained from the femoral heads of patients undergoing joint re- 
placement surgery. Rotenone, 3-nitropropionic acid (NPA), an- 
timycin A, sodium azide and oligomycin were employed to in- 
hibit complex I, II, III, IV or V of CRM, respectively. LPS was em- 
ployed as positive control. Cell viability was evaluated using the 
